.Welcome to this week's Chutes & Ladders, our summary of substantial management hirings, firings ...
.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer sounded ...
.AbbVie has actually come back to the source of its own antipsychotic giant Vraylar looking for yet ...
.GenSight Biologics is full weeks off of losing money. Again. The biotech only possesses adequate ca...
.Monopar Therapies is recovering a medication coming from the scrap heap of AstraZeneca's uncommon i...
.With brand new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of expert...
.After developing a genetics treatment alliance along with Dyno Rehabs in 2020, Roche is actually ba...
.Lundbeck is actually lowering the book value of its $250 million Abide Therapeutics buyout in respo...
.The integration of real-world information (RWD) into method expediency as well as web site assortme...
.At this year's Strong Biotech Top in Boston ma, we caught up with innovators in the biotech field t...